IBT
VERA icon

International Biotechnology Trust’s Vera Therapeutics VERA Stock Holding History

International Biotechnology Trust’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$10.4M Sell
758,355
-216,872
-22% -$3.72M 3.5% 7
2023
Q2 		$15.6M Sell
975,227
-27,030
-3% -$244K 4.76% 6
2023
Q1 		$7.75M Buy
1,002,257
+721,000
+256% +$5.57M 2.16% 16
2022
Q4 		$5.43M Hold
281,257
– – 1.68% 21
2022
Q3 		$5.99M Buy
281,257
+277,432
+7,253% +$5.19M 1.92% 17
2022
Q2 		$281K Sell
3,825
-186,924
-98% -$3.26M 2.93% 12
2022
Q1 		$11.6M Buy
190,749
+70,214
+58% +$1.51M 2.62% 13
2021
Q4 		$3.2M Buy
+120,535
New +$2.67M 0.71% 34

Other funds holding VERA

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

International Biotechnology Trust's VERA Position: Q3 2023 in Review

International Biotechnology Trust reduced its Vera Therapeutics (VERA) stake by 22% in Q3 2023, selling an estimated $3.72M and leaving 758,355 shares worth $10.4M. The position accounts for 3.5% of the portfolio, ranked #7.

International Biotechnology Trust first reported a position in VERA in Q4 2021 and has held it in 8 quarters since. The position peaked at $15.6M in Q2 2023. 84 funds tracked by Wall St. Rank hold VERA as of Q3 2023.

  • International Biotechnology Trust held 758,355 shares of Vera Therapeutics worth $10.4M as of Q3 2023.
  • International Biotechnology Trust sold 216,872 Vera Therapeutics shares in Q3 2023, an estimated $3.72M.
  • Vera Therapeutics made up 3.5% of International Biotechnology Trust's portfolio in Q3 2023, its #7 holding.
  • International Biotechnology Trust first reported a position in Vera Therapeutics in Q4 2021 and has held it in 8 quarters since.
  • International Biotechnology Trust's Vera Therapeutics position peaked at $15.6M in Q2 2023.
  • 84 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.